Sarcopenia in Pediatric Liver Transplant Recipients: Prevalence, Outcomes, and Systematic Review

Sarcopenia in Pediatric Liver Transplant Recipients: Prevalence, Outcomes, and Systematic Review

This systematic review and meta-analysis investigates the prevalence and impact of sarcopenia in children who have undergone liver transplantation. Sarcopenia, a condition characterized by muscle loss, is a significant concern in this population, as it can negatively affect post-transplant recovery, functional capacity, and overall quality of life.

Key findings:

• Prevalence: The review summarizes the reported prevalence of sarcopenia in pediatric liver transplant recipients, highlighting the variation across studies.
• Outcomes: The analysis explores the relationship between sarcopenia and important post-transplant outcomes, such as physical function, quality of life, and long-term survival.
• Factors: The study identifies potential risk factors for sarcopenia development in children after liver transplantation, including pre-transplant nutritional status, post-transplant complications, and medications.

Significance: This comprehensive review provides valuable insights into the prevalence, consequences, and potential risk factors associated with sarcopenia in pediatric liver transplant recipients. These findings can inform clinical practice, guiding the development of preventive strategies and targeted interventions to address this prevalent and clinically significant condition.

Methodological Approach:

The review follows a systematic and rigorous methodology, conducting a comprehensive search of relevant literature, applying predefined inclusion and exclusion criteria, and employing appropriate meta-analytic techniques to synthesize the findings of multiple studies.

Target Audience:

This review is of interest to healthcare professionals involved in the care of pediatric liver transplant recipients, including physicians, nurses, dieticians, and physical therapists. The findings can also benefit researchers seeking to deepen our understanding of sarcopenia in this population and develop evidence-based interventions to improve patient outcomes.